Canton Strategic Holdings (CNTN) Other financing activities (2024 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Other financing activities came in at $94711.0 in Q1 2026, down 96.21% on a QoQ basis from $2.5 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Other financing activities (2024 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 4 years of Other financing activities data on file, last reported at $94711.0 in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $94711.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, down 9.24% from the prior year.
- Other financing activities retreated to $94711.0 in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $3.6 million in Q4 2024 to a low of -$13.6 million in Q4 2022.
- A 4-year average of -$1.0 million and a median of $545587.5 in 2024 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 588.14% in 2025, down 31.44% in 2025.
- Tracing CNTN's Other financing activities over 4 years: stood at -$13.6 million in 2022, then soared by 126.77% to $3.6 million in 2024, then plunged by 31.44% to $2.5 million in 2025, then tumbled by 96.21% to $94711.0 in 2026.
- The last three Other financing activities figures came in at $94711.0 (Q1 2026), $2.5 million (Q4 2025), and $952725.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68,981.00 |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 6.26 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Dec 31, 2024 | 2.02 Mn |